S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
T   38.00 (-3.80%)
BAC   32.94 (-0.06%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
T   38.00 (-3.80%)
BAC   32.94 (-0.06%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
T   38.00 (-3.80%)
BAC   32.94 (-0.06%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
T   38.00 (-3.80%)
BAC   32.94 (-0.06%)
DIS   148.38 (+0.49%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 TocagenCheckpoint TherapeuticsNorthwest BiotherapeuticsOASMIA PHARMACE/ADRMersana Therapeutics
SymbolNASDAQ:TOCANASDAQ:CKPTOTCMKTS:NWBONASDAQ:OASMNASDAQ:MRSN
Price Information
Current Price$0.58$1.53$0.21$1.55$2.60
52 Week RangeHoldBuyN/AN/ABuy
Analyst Ratings
Consensus RecommendationHoldBuyN/AN/ABuy
Consensus Price Target$11.42$15.00N/AN/A$9.50
% Upside from Price Target1,868.10% upside880.39% upsideN/AN/A265.38% upside
Trade Information
Market Cap$14.24 million$68.01 million$132.72 million$116.20 million$131.20 million
Beta3.892.811.540.961.51
Average Volume404,75179,8371,108,19524,780242,959
Sales & Book Value
Annual Revenue$18.04 million$3.51 million$410,000.00$220,000.00$10.59 million
Price / Sales0.7716.56311.04528.2011.76
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.91 per share$0.42 per share($0.09) per share$0.63 per share$0.38 per share
Price / Book0.203.64-2.372.466.84
Profitability
Net Income$-48,960,000.00$-36,370,000.00$-35,790,000.00$-18,950,000.00$-64,260,000.00
EPS($2.44)($1.27)N/AN/A($2.79)
Trailing P/E RatioN/AN/A0.000.00N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-201,488.91%-583.52%N/A-8,633.64%-79.49%
Return on Equity (ROE)-182.15%-339.99%N/A-43.94%-41.14%
Return on Assets (ROA)-82.01%-158.34%-176.35%-28.92%-28.14%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.46%N/AN/AN/A0.06%
Current Ratio1.43%1.80%0.09%0.80%5.12%
Quick Ratio1.43%1.80%0.09%0.73%5.12%
Ownership Information
Institutional Ownership Percentage33.31%14.16%0.01%0.11%83.98%
Insider Ownership Percentage10.90%9.80%27.80%N/A29.20%
Miscellaneous
Employees777145786
Shares Outstanding23.90 million38.00 million597.31 million74.97 million47.88 million
Next Earnings Date2/26/2020 (Estimated)3/20/2020 (Estimated)2/11/2020 (Estimated)N/A3/13/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
 TocagenCheckpoint TherapeuticsNorthwest BiotherapeuticsOASMIA PHARMACE/ADRMersana Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel